Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiinflammatory cytokine modulators described by Amgen

Aug. 12, 1998

Kyowa Hakko discovers PDE IVA inhibitors for a range of potential indications

Aug. 12, 1998

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Aug. 11, 1998

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Aug. 11, 1998

New antiasthmatic PDE IV inhibitors revealed by Celltech

Aug. 10, 1998

PDE inhibitors from Kyorin useful as bronchodilators

July 31, 1998

Bronchodilators with a pyrrolopyrazolopyrimidine structure patented by Pola

July 29, 1998

Inhibitor of IgE antibody production discovered by Asahi Chemical

July 29, 1998

Novel antiasthmatic TYB-2285 reported to inhibit late asthmatic response and histamine release

July 29, 1998

SB-209670 improves ischemia-reperfusion injury in canine lung allografts

July 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.